Irish researchers to lead €3 million study on new cystic fibrosis medication

By Mindo - 05th Aug 2020 | 120 views

Pictured are Annabel Murphy (aged 8) who has cystic fibrosis with Prof Paul McNally, RCSI Associate Professor of Paediatrics, at the launch of a new €3 million study, led by the RCSI, to investigate the real-world effects of a new cystic fibrosis medication. Researchers at the RCSI University of Medicine and Health Sciences are leading the international research project, called RECOVER, to look at how a new triple combination cystic fibrosis drug, Kaftrio, will affect people in their day-to-day lives. The project has been awarded €2.85 million from the Cystic Fibrosis Foundation (US), €112,000 from the Cystic Fibrosis Trust (UK), and €100,000 from Cystic Fibrosis Ireland.

Leave a Reply

Latest Issue
Medical News 28th November
The Medical Independent 28th November 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read